California Stem Cell Agency Withholds $5.8 Million from Orchard in Bubble-Baby Flap
Money to Go to New Effort Involving Compassionate Use
Donald Kohn, the UCLA scientist who developed the bubble-baby treatment, UCLA photo
The California stem cell agency today said it plans to withhold as much as $5.8 million from a company that declined to provide “compassionate use” treatment of 20 children suffering from a grave immune deficiency known as the bubble baby disease.
The firm involved is Orch…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.